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Introduction {#sec1}
============

Germ cell development is a complicated multiple-step biological process. In mice, primordial germ cells (PGCs), the initial germ cell population, arise from proximal epiblast at embryonic day 6.5, and subsequently migrate to the genital ridge ([@bib12], [@bib13]). Fetal male PGCs transit into gonocytes/prespermatogonia and cease dividing. After birth, prespermatogonia resume proliferation and some become spermatogonial stem cells (SSCs) ([@bib10], [@bib13], [@bib31]). Spermatocytes then start to develop from differentiating spermatogonia *via* meiosis in a process called spermatogenesis, and subsequently mature into haploid spermatids ([@bib10], [@bib13], [@bib31]). Many important genes for mammalian germ cell development have been extensively studied in mice. Among them, BLIMP1 acts as a key regulator in fate specification of the earliest germ cell population PGCs ([@bib27]), whereas NANOS3+ and MVH+ cells represent the migrating PGCs and post-migrating gonocytes, respectively, in mice ([@bib35], [@bib38]). Thus, null mutations of these genes lead to defects in the formation of PGCs or gonocytes before birth ([@bib27], [@bib35], [@bib38]). In addition, PLZF, ID4, DMRT1, and GFRα1 (the receptor of GDNF) are highly expressed in post-natal SSCs, and play important roles in SSC self-renewal ([@bib4], [@bib7], [@bib15], [@bib16], [@bib41], [@bib43]). By contrast, SYCP3 (an essential member of the synaptonemal complex in meiosis), PRM1 (a protein that replaces histones in sperm DNA packaging), and ACR (ACROSIN, a major component in the acrosome of haploid spermatids), indicate the formation of meiotic cells in spermatogenesis ([@bib11], [@bib21], [@bib30]). As such, these genes are well-established markers of germ cells at distinct developmental stages.

In humans, about 15% of couples suffer from male infertility with half due to male factors, but a large number of which is idiopathic ([@bib23], [@bib26]). The most commonly identified cause of non-obstructive azoospermia (NOA) so far is attributed to various deletions in long arm of Y chromosome (Yq) ([@bib33], [@bib37]). The top three Yq deletion intervals related to NOA were thus named as azoospermia factors (AZFs; AZFa, AZFb, and AZFc) ([@bib33], [@bib37]). Previously, using a human-to-mouse xenotransplantation model, [@bib28] demonstrated reduced formation of germ cell-like cells (GCLCs) *in vivo* from induced pluripotent stem cells (iPSCs) of AZF-deleted patients. However, the developmental potential and properties of these GCLCs from diseased NOA-iPSCs are yet to be fully characterized. In addition, although a number of genes (such as NANOS3) are proven crucial during murine germ cell development, their relevance to human reproduction remains to be determined mainly due to the limited access to human tissues and the lack of experimental tools.

Pluripotent stem cells (PSCs) and iPSCs possess the potential to differentiate into all lineages of cells in the body, including germ cells, thereby serving as a valuable tool to investigate regulatory mechanisms underlying germ cell development ([@bib34], [@bib36]). Technical advances in the past several years make it possible to efficiently derive early germline cells from PSCs. For example, PGC-like cells (PGCLCs), can now be robustly induced from PSCs in both human and mice ([@bib14], [@bib17], [@bib32]), in which BLIMP1 plays a conserved and essential role ([@bib1], [@bib17], [@bib32]). In addition, functional spermatids have been generated from murine PGCLCs upon co-culture with neonatal testicular somatic cells and subsequent exposure to morphogens and sex hormones ([@bib44]). However, *in vitro* recapitulation of post-natal spermatogenesis, during which SSCs and haploid spermatids develop, remains to be a fundamental challenge in human biology.

Differentiation of PSCs into germ cells are commonly induced using undefined medium supplemented with fetal bovine serum (FBS), which contains unknown quantities of growth factors. The efficiency of germ cell derivation across laboratories is often inconsistent, reflecting the difficulties in standardizing use of serum, feeder cells, and animal products from batch to batch. [@bib9] recently described a protocol to robustly induce spermatogonium-like cells (SLCs) from human PSCs using defined SSC culture medium, yet still relying on STO feeders and animal products such as BSA. In addition, it remains to be determined whether these *in-vitro-*derived SLCs bear similarity in gene expression patterns with the *in-vivo-*developed spermatogonia by global transcription profiling. Further, it is of great interest to investigate whether this protocol can be utilized to recapitulate the human germ cell development under various pathological conditions. In this study, we developed a feeder-, serum-, and animal product-free culture condition, and successfully induced a high percentage of SLCs from human PSCs. Genome-wide expression analyses demonstrated a significant upregulation of germ cell-specific genes in SLCs derived from PSCs compared with *in-vivo*-isolated human CD90+ SSCs. In addition, we demonstrated that this protocol could be utilized *in vitro* to evaluate the developmental potential of SLCs from PSCs with depletion of germ cell-specific gene *NANOS3*, and from iPSC lines derived from NOA patients.

Results {#sec2}
=======

Derivation of SLCs from Human PSCs under a Feeder-, Serum-, and Xeno-free Condition {#sec2.1}
-----------------------------------------------------------------------------------

In the protocol [@bib9] described, STO feeders and SSC culture medium with 18 different components including 2-mecaptoethanol were utilized. However, with this protocol, we found a large portion of PSCs went through apoptosis during induction ([Figure S1](#mmc1){ref-type="supplementary-material"}A), which may partially explain the substantially varied derivation efficiency across different iPSC cell lines in our hands. As 2-mecaptoethanol was shown to affect cell proliferation ([@bib6]), whereas vitamin C may promote survival of SSCs and expression of germline genes ([@bib3], [@bib39]), we optimized the culture medium by removal of 2-mercaptoethanol and inclusion of vitamin C. Using crystal violent staining and an MTT assay to indicate cell survival, as well as apoptosis analyses to monitor cell death, we demonstrated that a healthy differentiation culture was easily maintained across different PSC lines with more viable cells and fewer cell deaths in the optimized protocol ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A--S1C). More importantly, we were able to efficiently induce PLZF+ SLCs in the optimized medium on gelatin without any feeder cells ([Figure 1](#fig1){ref-type="fig"}B). To minimize the use of animal products in future clinical therapy, and to reduce induction variability, we further replaced BSA with 0.2%--3% xeno-free serum replacement without animal products, and obtained the comparable percentage of PLZF+ SLCs with the ones using BSA ([Figure S1](#mmc1){ref-type="supplementary-material"}D, top panel).Figure 1Feeder-, Xeno-, and Serum-free Induction of SLCs from hESCs(A) Crystal violent staining of SLC colonies derived from hESCs (H1) under different conditions. Vc, vitamin C; 2ME, 2-mercaptoethanol. Cell numbers were measured by MTT assay and shown on the right. Relative absorbance of samples at 490--650 nm was calculated. Data are represented as mean of fold changes (compared with the one without Vc and 2ME) ± 1 SEM from three independent experiments.(B) Flow cytometry analyses of PLZF+ cells on differentiated H1 hESCs under different conditions.(C) Real-time RT-PCR analyses of germ cell-specific genes at various time points along H1 hESC differentiation. Data are represented as mean ± 1 SEM from three independent experiments.(D) IF assays of germ cell-specific genes performed at various time points along H1 hESC differentiation. Day 10, D10; Scale bar, 50 μm.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

We next characterized the gene expression profiles along the time course of SLC induction. We found that the expression of *BLIMP1*, the early PGC marker, peaked at days 5--9 post-induction, followed by increased expression of key regulators that indicate formation of post-migrating gonocytes, including *MVH*, *DAZL, NANOS2, NANOS3,* and *PIWIL4* between days 12 and 25 ([Figure 1](#fig1){ref-type="fig"}C, top panel). The levels of spermatogonial markers such as *PLZF*, *DMRT1*, *ID4*, and *GFRα1* were also significantly elevated during induction ([Figure 1](#fig1){ref-type="fig"}C, middle panel). Interestingly, *TNP1*, the gene indicating formation of haploid cells was increased as well ([Figure 1](#fig1){ref-type="fig"}C, bottom panel), suggesting the emergence of meiotic spermatocytes and putative spermatids. Consistent with upregulated transcript levels of these germline genes, immunofluorescence (IF) assays revealed BLIMP1+ cells at day 10 post-induction ([Figure 1](#fig1){ref-type="fig"}D). These BLIMP1+ were not co-expressed with PLZF, suggesting that PLZF+ cells are not PGCs. In contrast, the germ cell-specific proteins MVH and DAZL were readily detected from the differentiated population on day 15 post-induction ([Figure S1](#mmc1){ref-type="supplementary-material"}E). MVH and markers of spermatogonia (e.g., GPR125 and CD90) were largely co-stained with PLZF from days 12 to 15 during PSC differentiation ([Figure 1](#fig1){ref-type="fig"}D), indicating these PLZF+ cells are SLCs.

Putative Haploid Cells Developed from SLCs {#sec2.2}
------------------------------------------

We next examined if these SLCs could go through meiosis to generate haploid spermatids. While it is difficult to obtain definitive evidence for proper segregation of homologous chromosomes, we performed DNA spreading assays using antibodies against SYCP3 and CENPA (a component of centromere) as markers of meiosis. A very small fraction of the differentiated cells (\<1%) exhibited positive staining of SYCP3, but not any of their parental H1 human embryonic stem cells (hESCs) ([Figure 2](#fig2){ref-type="fig"}A). Further, the flow cytometry assay detected less than 5% haploid cells among the differentiated cells around day 12 post-induction from ESCs ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}D, bottom panel). These haploid cells were collected and subjected to IF staining. Consistent with the data described above, some of these sorted haploid cells were stained positive for ACR, a unique marker for acrosome with perinuclear localization in spermatids, and as well as for PRM1, the protein protamine replacing histone in spermatids ([Figure 2](#fig2){ref-type="fig"}C). DNA content of haploid population was further analyzed *via* fluorescence *in situ* hybridization (FISH). We clearly observed that these sorted haploid cells were stained exclusively with either X or Y sex Chr, and one copy of Chr 18, or Chr 7; by contrast, the diploid cells isolated from same culture harbored both X and Y chromosomes, as well as two copies of Chr 18 or Chr 7 in the same nuclei ([Figures 2](#fig2){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}C), thus confirming these sorted cells with true haploid property. In summary, our data suggest that a small proportion of SLCs induced under this feeder-free condition may have the potential to go through meiosis and form haploid cells.Figure 2Human SLCs Undergo Meiosis and Form Putative Haploid Cells(A) Meiosis DNA spreading assays were performed with antibodies against CENPA and SYCP3 on H1 hESCs and their derivative SLCs at day 11 post-differentiation. Scale bar, 5 μm.(B) Flow cytometry analyses of percentage of haploid cells formed from H1 ESCs at various time points along differentiation. Mouse testes were used as control.(C) IF of key proteins that participated in meiosis, including ACR and PRM1, on sorted haploid cells differentiated from H1 ESCs at day 12. Scale bar, 10 μm.(D) FISH analyses of sex chromosomes and Chr 18 on diploid cells and haploid cells sorted from the same differentiation culture at day 12. Scale bar, 5 μm.(E) Bisulfate sequencing on imprinting loci of parental H1 ESCs, SLCs, sorted haploid cells at day 12 post-differentiation, and spermatids collected from biopsied human testes. White circles, unmethylated CpG; black circles, methylated CpGs.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

One unique feature of a germ cell is its characteristic changes in imprinting status during development: DNA methylation at imprinted loci is removed at the PGC stage and re-established in spermatogenesis ([@bib2], [@bib24]). With bisulfate sequencing, we demonstrated that the paternal imprinted loci of *H19* were highly methylated in SLCs and in sorted haploid cells, as one would expect for *in vivo* collected spermatids ([Figure 2](#fig2){ref-type="fig"}E). Similarly, the DNA methylation levels of maternal imprinted *PEG10* and *SNRPN* regions were decreased compared with those of undifferentiated parental H1 ESCs. However, these maternal imprinted loci were not completely demethylated as the *in vivo* haploid control were ([Figure 2](#fig2){ref-type="fig"}E). Therefore, these *in-vitro-*derived haploid cells may need to be further reprogrammed to fully mirror their *in vivo* counterparts.

Genome-wide Analyses of *In-Vitro*-Derived SLCs and Haploid Cells from PSCs {#sec2.3}
---------------------------------------------------------------------------

To determine if SLCs derived from PSCs have similar gene expression patterns as their *in vivo* counterparts at genome-wide level, CD90+ cells enriched for spermatogonia were isolated from biopsied human testes of two obstructive azoospermia (OA) patients, and their transcript profiles were compared with those of *in-vitro-*induced SLCs *via* RNA sequencing. We also included PSCs with enforced PLZF expression in this assay to explore the potential role of PLZF during germ cell derivation. We did not observe much significant alteration of SCL formation or gene expression profiles upon PLZF overexpression ([Table S1](#mmc2){ref-type="supplementary-material"}), suggesting that PLZF itself is not enough to drive PSCs to become SLCs. Principal-component analysis showed a directional and progressive transition of cellular properties of SLCs toward *in vivo* CD90+ spermatogonia ([Figure 3](#fig3){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}).Figure 3Gene Expression Analyses on SLCs and Sorted Haploid Cells Derived from iPSCs(A) Principal-component analysis (PCA) analyses on PSCs, SLCs from day 12 of PSC differentiation (12d) with or without PLZF overexpression (OE), and CD90+ spermatogonia sorted from biopsied testes of OA patients.(B) Dendrogram hierarchy clustering performed on PSCs, SLCs, and CD90+ cells sorted from biopsied testes of OA patients.(C) Heatmap on 1,815 transcripts enriched with germ cell-specific factors and genes highly expressed in CD90+ cells were analyzed on PSCs, SLCs, and CD90+ cells collected from biopsied samples.(D) Violin map of transcript expression of germ cell-specific genes were analyzed on PSCs, SLCs, and sorted CD90+ cells. ^∗∗^p \< 0.01.(E) Real-time RT-PCR analyses of germ cell-specific genes in PSCs or SLCs from day 12 of PSC differentiation with and without PLZF overexpression, compared with *in-vivo-*isolated CD90+ spermatogonia.(F) Real-time RT-PCR analyses of genes involved in meiosis on PSCs, or haploid cells sorted from differentiated PSCs, compared with *in-vivo-*formed round spermatids isolated from two OA patients. (E and F) Data are represented as mean ± 1 SEM from four independent experiments.^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

We next investigated whether those SLCs were enriched with germ cell-related genes. After interrogating 29 online gene ontology (GO) terms from EMBL_EBI, we pulled out 761 transcripts with purported roles in germ cell development and low expression (with fragments per kilobase of transcript per million mapped reads \[FPKM\] \< 0.23) in undifferentiated PSCs. In addition, we included 350 transcripts that were related to stem cells from GO terms and 926 transcripts that were highly expressed in the CD90+ cells from this study ([Table S3](#mmc4){ref-type="supplementary-material"}). Therefore, in total the levels of 1,815 transcripts (1,101 unique genes) were examined on both *in-vitro-*derived SLCs and *in vivo* CD90+ cells ([Figure S3](#mmc1){ref-type="supplementary-material"}B; [Table S3](#mmc4){ref-type="supplementary-material"}). Both cluster and heatmap analyses revealed that the expression patterns of germline genes in PLZF+ cells closely resembled those of CD90+ spermatogonia, but not their parental PSCs ([Figures 3](#fig3){ref-type="fig"}B and 3C; [Tables S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}). Upon excluding the 350 transcripts that were expressed in PSCs, violin map analyses clearly demonstrated an increased expression pattern of germ cell-specific transcripts in SLCs and PLZF-overexpressed cells toward CD90+ spermatogonia ([Figure 3](#fig3){ref-type="fig"}D). The key genes enriched in SLCs included *PLZF*, *GFRα1*, *ID4*, *NANOS3*, *DMRT1/3*, and *PIWIL4*, etc. ([Figure S3](#mmc1){ref-type="supplementary-material"}C), all of which are important for germ cell development ([@bib4], [@bib5], [@bib7], [@bib15], [@bib22], [@bib38]). We confirmed the high expression of these genes with independent real-time RT-PCR assays ([Figures 3](#fig3){ref-type="fig"}E, [S3](#mmc1){ref-type="supplementary-material"}D, and S3E).

We also examined the transcript levels of genes involved in the development of ectoderm (45 transcripts), mesoderm (227 transcripts), and endoderm (109 transcripts), respectively ([Table S4](#mmc5){ref-type="supplementary-material"}). Interestingly, 40%--50% of genes related to mesoderm and 36%--39% to endoderm development were upregulated in both CD90+ cells and PSC-derived SLCs, much higher than the percentage of genes (24%) involved in ectodermal lineage specification ([Figure S3](#mmc1){ref-type="supplementary-material"}F). These observations thus suggest a potential correlation of germ cell development and endo-mesodermal differentiation.

We further sorted PSC-derived haploid cells, and compared their expression patterns with those of *in-vivo-*isolated haploid spermatids from OA patients. Interestingly, the expression of 98 meiosis-indicative transcripts, including *PRM1*, *TNP1*, and *SPATA19*, etc., was significantly upregulated in haploid cells from both sources ([Figures 3](#fig3){ref-type="fig"}F and [S3](#mmc1){ref-type="supplementary-material"}G; [Table S3](#mmc4){ref-type="supplementary-material"}), albeit at relatively lower transcript levels observed from the *in-vitro-*derived haploid population compared with the ones developed *in vivo*. Taken together, our results demonstrate that the *in-vitro-*derived SLCs and haploid cells from PSCs bear high similarity with their *in vivo* counterparts in the expression of key genes during germ cell development.

NANOS3 Deficiency Compromises the Formation of SLCs from PSCs {#sec2.4}
-------------------------------------------------------------

*NANOS3* is a conserved germ cell-specific gene, and has been used as a marker for human PGCLCs ([@bib17], [@bib38]). We found that NANOS3 was highly expressed during PSC differentiation toward SLCs ([Figure 1](#fig1){ref-type="fig"}C), and thereby indicates a role of NANOS3 in SLC derivation. To investigate whether our differentiation system can reflect altered germ cell development, and to delineate the function of NANOS3 in this process, we created several *NANOS3* knockout H1 ESC lines *via* CAS9/CRISPR techniques ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B) ([@bib29]). We compared three cell lines with large deletions in the first exon of *NANOS3* gene against a control line without any mutation ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Marked reduction of *NANOS3* expression in these mutated lines was confirmed by real-time RT-PCR assays ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In addition, compared with wild-type control PSCs, all three lines with *NANOS3* deletion displayed significantly fewer PLZF+ cells during differentiation ([Figure 4](#fig4){ref-type="fig"}A). Consistently, the transcript levels of *PLZF*, *DMRT3*, and *GFRα1* were dramatically reduced in NANOS3-deficient lines ([Figure 4](#fig4){ref-type="fig"}B). Interestingly, expression levels of two genes (i.e., *BLIMP1* and *SOX17*) in PGC formation were largely upregulated ([Figure 4](#fig4){ref-type="fig"}B), suggesting a possible accumulation of early germ cell progenitors due to blockage of SLC formation. Taken together, these data prove that our *in vitro* differentiation system is able to recapitulate disturbed germ cell formation upon loss of function of key germline genes such as *NANOS3*.Figure 4NANOS3 Deficiency Affects Formation of SLCs from PSCs(A) Flow cytometry analyses of PLZF+ cells on wild-type H1 ESCs or ESCs with NANOS3 null mutations at day 13 post-differentiation.(B) Real-time RT-PCR analyses on wild-type H1 ESCs or ESCs with NANOS3 deletions at day 13 post-differentiation. Data are represented as mean ± 1 SEM from three independent experiments. ^∗∗∗^p \< 0.001.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Establishing iPSC Lines from NOA Patients {#sec2.5}
-----------------------------------------

To further evaluate whether our protocol can be used to model pathological germ cell development *in vitro*, we obtained six iPSC lines from four NOA patients and two male controls. Of these, five lines were derived from skin biopsy samples with classical retroviral infection, and one (i.e., P24) from peripheral blood cells using electroporation with non-integrated episomal plasmids to introduce core pluripotency factors ([@bib40]). Among four patients, two (P2369 and P2656) were diagnosed as NOA with Sertoli cell-only syndrome, whereas two (P2514 and P2618) had microdeletions at the AZFc locus in both parental fibroblasts and established iPSC lines, as detected by PCR-based analyses of Yq genomic markers (Yq sequence-tagged sites) ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). We predicated that these microdeletions would lead to reduced DNA copies of multiple coding genes in the AZFc region according to the genomic map ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Further qPCR analyses indeed demonstrated fewer copies of *BPY2*, *DAZ*, and *CDY1* in fibroblasts and iPSC lines from patients P2514 and P2618 ([Figure S5](#mmc1){ref-type="supplementary-material"}C). In addition, these iPSC lines exhibited the same DNA fingerprinting of short tandem repeats as their source somatic cells ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Collectively, our data demonstrate that these iPSC lines faithfully reflect the genotypes of patients and control donors.Figure 5Establishing iPSCs from NOA Patients(A) PCR detection of Y-Chr microdeletion with sequence-tagged site in control hESCs (H1), derived iPSC lines, and their parental fibroblasts.(B) A representative karyotyping image from iPSC line P2514 derived from NOA patients.(C) Morphology, AP staining, and IF analyses of pluripotency factors (including OCT4, NANOG, TRA-1-60, and TRA-1-81) on established iPSC lines and control hESCs (H1). Scale bar, 100 μm.(D) Exogenous expression of transgenes used in the derivation of iPSC lines.(E) RT-PCR analyses of key genes in three germ layer development on embryoid bodies differentiated from control hESCs (H1) and established iPSC lines.(F) Histology analyses on teratoma sections from control hESCs (H1) and iPSC lines. Scale bar, 50 μm.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

These iPSC cells are morphologically similar to hESCs. They proliferated every 5--7 days per passage and displayed normal karyotypes (22, XY) as human cells ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}E). They exhibited high alkaline phosphatase activities and expressed pluripotency markers, including TRA-1-81, TRA-1-60, OCT4, and NANOG, similar to the existing hESC line H1 at both transcript and protein levels ([Figures 5](#fig5){ref-type="fig"}C, [S6](#mmc1){ref-type="supplementary-material"}A, and S6B). No exogenous gene expression was detected in these iPSCs at the passages that we used for differentiation ([Figure 5](#fig5){ref-type="fig"}D).

During spontaneous differentiation of these iPSC lines *via* embryoid body formation, we observed expression of key genes in three-germ-layer development at levels that were comparable with differentiated H1 ESCs under the same conditions ([Figures 5](#fig5){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}C). All iPSC lines formed teratomas within 2 months post-injection into nude mice, and derivatives from three germ layers were clearly observed from tumor sections ([Figure 5](#fig5){ref-type="fig"}F), suggesting that these iPSCs possess normal differentiation potential as ESCs. Taken together, these data confirm that we have successfully established iPSC lines from NOA patients and controls.

Modeling Germ Cell Development from NOA-iPSC Lines {#sec2.6}
--------------------------------------------------

We next investigated the potential of NOA-iPSCs in germ cell development *in vitro*. Interestingly, we found a significantly reduced percentage of PLZF+ cells upon induction in two iPSC lines (P2369 and P2656) from NOA patients with Sertoli cell-only syndrome ([Figure 6](#fig6){ref-type="fig"}A), albeit that their differentiation ability into three germ layers remained normal. Consistently, their transcript levels of *PLZF*, *GFRα1*, or *DMRT3* were also significantly decreased ([Figure 6](#fig6){ref-type="fig"}B). No PLZF+/GPR125+ cells at day 12 post-differentiation in these two lines were detected by IF ([Figure 6](#fig6){ref-type="fig"}C). In addition, very few haploid spermatids were developed from these two differentiated NOA-iPSC lines ([Figure 6](#fig6){ref-type="fig"}D). By contrast, the other two NOA-iPSC lines with AZFc microdeletion displayed a relatively normal amount of PLZF+ SLCs and slightly fewer haploid cells, compared with normal PSC lines ([Figure 6](#fig6){ref-type="fig"}D), in agreement with their relatively mild symptoms of blocked spermatogenesis in clinical diagnosis. In summary, these data demonstrate that our protocol provides a feasible tool to evaluate both physiological and pathological processes of germ cell developments *in vitro*.Figure 6Evaluating Germ Cell Developmental Potential from NOA-iPSCs(A) Percentage of PLZF+ cells analyzed by flow cytometry on differentiated NOA-iPSCs, control iPSCs, and H1 ESCs, at days 12--15 post-induction. At least three iPSC clones from each NOA patient and P34 control were independently examined. Each dot in the graph represents one independent differentiation experiment.(B) Real-time RT-PCR analyses of spermatogenesis-related genes in SLCs from differentiated NOA-iPSCs and control H1 ESCs.(C) IF assays of spermatogonium-related genes performed at day 12 post-differentiation of NOA-iPSCs and control H1 ESCs. Scale bar, 50 μm.(D) Flow cytometry analyses of putative haploid spermatids from differentiated NOA-iPSCs at day 12 compared with wild-type hESCs (H1) or control iPSCs (P34). iPS 0d: undifferentiated iPSC line P34. (B and D) Data are represented as mean ± 1 SEM from more than six independent experiments.^∗^p \< 0.05; ^∗∗^p \< 0.01.

Discussion {#sec3}
==========

Development of *in vitro* differentiation models of PSCs into germ cells will greatly facilitate research on human reproduction. Despite recent advances in early PGC derivation ([@bib14], [@bib17], [@bib32]), formation of late spermatogonia from PSCs and *in vitro* recapitulation of human male infertility remain as major challenges. In this study, we circumvented the problem of cell death in the [@bib9] protocol with medium optimization by removing 2-mercaptoethanol and adding vitamin C. We successfully developed a standardized and reproducible feeder- and xeno-free protocol that enables efficient differentiation of human PSCs toward SLCs. Using this system, we revealed that NANOS3 deficiency compromised SLC derivation from human PSCs. In addition, we demonstrated dramatically decreased formation of SLCs and haploid cells upon differentiation of NOA-iPSC lines from patients with Sertoli cell-only syndrome. These findings prove our system to be a powerful tool to investigate molecular pathways that govern germ cell development and to understand pathological causes of human male infertility.

In our model, *in-vitro-*derived SLCs displayed key features of spermatogonia, with upregulation of germline genes and specific epigenetic imprinting patterns, albeit that their global transcript dynamics were somewhat different from *in-vivo*-isolated CD90+ cells. This may be the result of an incomplete induction of PSCs to germ cell lineages; alternatively, this can also be explained in part by the heterogeneity of differentiated cell populations. To date, few specific surface markers have been defined to identify prospermatogonia or spermatogonia at distinct developmental stages in humans. Although PLZF and CD90 are also expressed on somatic cells, these PLZF+ SLCs largely co-stained with the germ cell-specific marker MVH, suggesting their germline lineages. These PLZF+ SLCs likely represent a heterogeneous spermatogonial population enriched from the process of PSC differentiation. In addition, these SLCs exhibited significantly increased expression in key genes for PGC development (i.e., *BLIMP1*, *MVH*, *DAZL*, *NANOS2*, and *NANOS3*) and spermatogonial formation (i.e., *PLZF*, *ID4*, *GFRα1*, and *DMRT1*). Proteins for germ cell-specific genes MVH and DAZL were readily detected in the differentiated cell population on day 15 post-PSC induction. As one of the most important criteria to define germ cell lineages of derived spermatogonia is to examine whether they contribute to spermatogenesis *in vivo*, future investigation is required to determine whether these SLCs can reconstitute testes without endogenous germ cells.

The current differentiation protocol was optimized mainly for SLC formation, and the efficiency of meiosis is therefore not robust. Approximately 5% of haploid cells were generated using our system. However, the maternal imprinting loci *PEG10* and *SNRPN* in these haploid cells were not completely demethylated, as one would expect for their *in vivo* counterparts. In addition, the expressions of genes involved in meiosis were not upregulated to the level as sorted spermatids from testes. Therefore, further reprogramming for these *in-vitro-*derived haploid cells may be needed to fully mirror their *in vivo* counterparts. On the other hand, unlike their parental PSC lines or diploid cells collected from the same culture, these cells contained either the X- or Y-Chr and a single copy of Chr 7 or Chr 18, proving that they are true haploid cells and unlikely to come from aneuploidy caused by prolonged *in vitro* culture. Our data therefore suggest that a small portion of SLCs may have the capability to go through meiosis with appropriate induction; however, ultimately thorough functional evaluations are required to determine whether these *in-vitro-*derived haploid cells are competent spermatids to fertilize human oocytes. A recent report showed that mouse PGCLCs were able to complete meiosis upon co-culture with neonatal testicular somatic cells and sequential exposure to morphogens and sex hormones ([@bib44]). It will therefore be of great interest to explore whether these protocols for PGCLC derivation ([@bib17], [@bib32]), spermatogonial induction ([@bib9] and our study), and functional spermatid generation ([@bib44]) can be implemented synergistically to fully recapitulate the process of human germ cell development *in vitro*.

Of the four NOA-iPSC lines we investigated, two were from NOA patients with clinically diagnosed Sertoli cell-only syndrome. We demonstrated that these lines displayed significantly reduced formation of SLCs and haploid cells. This is unlikely due to differentiation variability among iPSC lines as the results were confirmed with at least three independent iPSC clones from each NOA patient. Furthermore, we utilized two iPSC derivation protocols, one of which was performed on peripheral mononuclear blood cells from a male control with non-integrating plasmids ([@bib40]). We obtained comparable efficiency in the SLC formation from control iPSCs using both protocols, and thus excluded potential impacts from residual exogenous genes on germ cell development that were introduced by iPSC derivation. In addition, deficiency of germ cell-specific gene NANOS3 indeed compromised SLC formation from PSCs, and thus prove that our PSC differentiation protocol is able to model the pathological germ cell development *in vitro*.

In the current study, relatively normal development of germ cells from two iPSC lines with AZFc microdeletion were observed. This is not surprising given that the human AZFc locus harbors multiple copies of coding genes, for example, four copies of DAZ, two of CDY1, and three of BPY2 ([@bib33], [@bib37]). In addition, some of these Y-Chr genes have autosome homologs. Examples include CDYL at Chr 13 as a homolog for CDY1, and DAZL at Chr 3 for DAZ ([@bib33], [@bib37]). Therefore, symptoms due to AZFc microdeletion are usually correlated with the specific copies of genes that are deleted, and may be compensated by their autosome homologs. Such gene amplification and redundancy during evolution not only reflect the physiological importance of these genes, but also allow for diversification and precise specification of their roles in human. However, this also makes it difficult to decipher the exact biological functions of these genes solely based on animal models. Therefore, our PSC *in vitro* differentiation protocol provides a much needed experimental platform to systematically investigate the unique roles of human-specific genes in germ cell development. Notably, DAZ only exists in human and primate genomes ([@bib18]). Although its homolog DAZL plays an indispensable role in mouse SSC formation, consistent with the findings in this study, patients with AZFc microdeletion (or with loss of DAZ gene) often have SSCs remaining in testes despite oligospermia at relatively later adulthood ([@bib25], [@bib37]). These suggest that genes (e.g., DAZ) at the AZFc region may not play eminent roles for the fate specification and self-renewal of human SSCs.

Recent studies just began to elucidate molecular players that govern the derivation of early germ cell progenitors from human PSCs. For example, [@bib17] found that activation of SOX17, a gene involved in endodermal fate specification, was essential for human PGCLC formation from naive PSCs, whereas [@bib32] reported that PGCLCs developed robustly from human PSCs through a stage called incipient mesoderm-like cells. The current study demonstrated that genes for mesoderm and endoderm differentiation were largely upregulated in these SLCs, supporting potential roles of meso-endodermal specifiers in human germ cell development. Although BLIMP1 and NANOS3 were both expressed in PGCLCs from mouse and human PSCs ([@bib17], [@bib38]), the expression of BLIMP1 peaked earlier than that of NANOS3, and was largely augmented upon NANOS3 deficiency in our culture. In addition, only about 5% BLIMP1+ cells developed from PSCs, much fewer than PLZF+ SLCs (\>50% in most lines). It is possible that BLIMP1+ PGCLCs only transiently appear before NANOS3+ germ cells during PSC differentiation. NANOS3 deficiency may reduce downstream SSCLC formation and in turn causes blocked PGCLC differentiation. Alternatively, it is also possible that NANOS3 but not BLIMP1 directly contributes to SLC development from PSCs. Future investigation into pathways that regulate human germ cell development will provide molecular and mechanistic insights into SSC fate specification.

Experimental Procedures {#sec4}
=======================

Testicular Biopsy, Skin Specimens, and Periphery Blood Sample Collection {#sec4.1}
------------------------------------------------------------------------

Testicular specimens were biopsied from three OA patients and immediately placed aseptically in PBS containing 1,000 units/mL penicillin and streptomycin (Gibco) for further analyses. Skin samples were obtained from four NOA patients and one male donor, whereas 2 mL peripheral blood was collected from the other male control. The diagnosis of OA and NOA patients were confirmed by pathological examination of testes *via* biopsy. This study was approved by the Institutional Ethical Review Committee of Ren Ji Hospital (license number 2012-01), Shanghai Jiao Tong University School of Medicine, and all participants provided written consent.

Cell Culture and hESC/iPSC Differentiation {#sec4.2}
------------------------------------------

Participant-specific PSCs were induced according to published protocols from skin biopsy samples, with the exception of iPSC line P24, which was established from peripheral blood cells ([@bib34], [@bib40]). Human ESC line H1 and iPSC lines were maintained in chemically defined Essential 8 medium (STEMCell Technologies). Cells were passaged every 5--7 days and dissociated by 1 mg/mL Collagenase IV (Millipore). We started to induce PSCs differentiation into germ cells in differentiation medium when they reached 80%--90% confluence (components of differentiation medium mentioned below all come from Invitrogen/Gibco, unless otherwise noted): A-MEM, 2 mM L-glutamine, 1× Insulin-Transferrin-Selenium-X, 0.2% BSA or substituted by 0.2%--3% KnockOut SR XenoFree CTS (Gibco), 1 ng/mL recombinant human basic fibroblast growth factor (bFGF), 20 ng/mL recombinant human GDNF (Sino Biological), 0.2% chemically defined lipid concentrate, and 200 μg/mL vitamin C (Sigma). Medium was changed every day until the collection of cells for analyses at each time point. No passage of cells was performed during differentiation. About 20%--30% of cells might have gone through cell death upon differentiation before day 6, but much less apoptosis was observed afterward. PLZF+ cells emerged around day 6, and by day 12, usually more than 50% of cells were PLZF+. We collected cells for analyses at days 12--15 post-differentiation, unless otherwise noted. For comparison performed in [Figure S6](#mmc1){ref-type="supplementary-material"}C, PSCs were differentiated *via* embryoid body formation in serum containing medium (Knockout DMEM supplied 20% FBS without bFGF, all from Gibco). PLZF overexpressing cell line was established by introducing PLZF transgene driven by EF1α promoter into H1 ESCs. For construction NANOS3 knockout PSC lines, H1 ESCs were infected with vector in which the expression of Cas9 could be induced by doxycycline. The lentiviral vector containing gRNAs specifically against NANOS3 and puromycin transgene were introduced afterward for selection of drug-resistant colonies. The region spanning the gRNA-targeted region was amplified from genomic DNA to confirm individual colonies that harbored null mutations of NANOS3 at both alleles. Primers and gRNA used in this study are listed in [Table S5](#mmc1){ref-type="supplementary-material"}.

IF Assays {#sec4.3}
---------

Cells were seeded and differentiated on cover slides or placed on slides by cytospin preparation, and fixed in 4% paraformaldehyde (PFA). IF was performed using the following primary antibodies: TRA-1-81 (sc-21706), TRA-1-60 (sc-21705), OCT4 (sc-9081), and PRM1 (sc-23107) from Santa Cruz Technologies; PLZF (MAB2944) from R&D; CD90 (ab133350), MVH (ab13840), and ACR (ab3983) from Abcam; GPR125 (GeneTex, GTX51219); NANOG (CST no. 3580S) and BLIMP1 (CST no. 9115S) from Cell Signaling Technology. The fluorescein-conjugated secondary antibodies (Jackson ImmunoResearch) were used at 1:200 dilution. Images were obtained with a Leica confocal microscope.

Flow Cytometry {#sec4.4}
--------------

Cells were dissociated by TrypLE, and fixed by 4% PFA for 20 min at room temperature. The fixed cells were suspended in fluorescence-activated cell sorting (FACS) buffer (PBS with 5% fetal calf serum, 0.2% Triton-100, and 0.5% Tween 20) for 25 min and centrifuged at 500 × *g* for 5 min before incubation with a PLZF antibody (R&D, MAB2944, 1:160 dilution) or a CD90 (BioLegend, 328109) antibody. Subsequently, the cells were washed with FACS buffer, detected with APC or PE-conjugated anti-mouse second antibody. For analyses of DNA content, dissociated cells were fixed with 0.5% PFA in PBS for 15 min, suspended in 0.1% Triton X-100 in PBS for 3 min, centrifuged at 200 × *g*, stained with 50 μg/mL PI (Invitrogen) and 100 ng/mL RNase (Invitrogen) at 4°C, and then analyzed with a FACS Calibur (BD Biosciences). To isolate haploid cells from *in-vitro-*differentiated PSCs or from patients\' biopsied testes, dissociated cells were stained at 37°C for 10 min in differentiation medium containing 15 μg/mL Hoechst 33,342 (Life Technologies) and then sorted by a FACS Aria II (BD Biosciences). Apoptosis analyses were performed using FITC-Annexin V Apoptosis Detection Kit from BD Pharmingen according to the manufacturer\'s instructions.

FISH {#sec4.5}
----

FISH assays were performed according to published protocols ([@bib9]). In brief, sorted cells were cytospun onto slides and fixed with Carnoy\'s fixative. The cytology specimens were further prepared using ZytoLight FISH-Cytology Implementation Kit according to the manufacturer\'s instructions (ZytoVision, Bremerhaven, Germany). Human chromosomes X, Y, and 7 were detected using ZytoLight CEN X/Y Dual Color Probe and Cen7 Probe kit (ZytoVision). Triple probes and detection kits for Chr X, Y, and 18 were purchased from Abbott Molecular. Nuclei were observed with co-staining of DAPI.

Meiotic DNA Spreading Assays {#sec4.6}
----------------------------

Meiotic DNA spreading assays were performed according to published protocols ([@bib8], [@bib18]) with minor modifications. In brief, the dissociated cells were suspended in hypo-extraction buffer (30 mM Tris, 50 mM sucrose, 17 mM Na citrate, and 5 mM EDTA, pH 8.3, Protease Inhibitor Cocktail/Santa Cruz Tech) and incubated on ice for 30 min. Following centrifugation, the cells were resuspended in 20 μL hypoextraction buffer with 60 μL 100 mM sucrose and cytospun at 180 × *g* for 3 min onto a slide. The cells were fixed in 4% PFA, and incubated with 0.04% photoflo (Kodak) for 5 min. Air-dried slides were blocked with 3% BSA for 30 min at room temperature and stained with SYCP3 (ab15093) and CENPA (ab13939) antibodies (both from Abcam) at 4°C overnight, and with fluorescein-conjugated secondary antibodies thereafter. Images were captured with a Leica confocal microscope.

Bisulfate Sequencing {#sec4.7}
--------------------

Genomic DNA was extracted using an E.Z.N.A. MicroElute Genomic DNA Kit (Omega Bio-Tek) according to the manufacturer\'s protocol. About 500 ng to 1 μg of genomic DNA was bisulfate-treated followed with PCR according to published protocols ([@bib19], [@bib20]). The PCR products were cloned into pEASY-T5 Zero Cloning Vector (TransGen Biotech), and 15 clones were sequenced for each sample. Primers are listed in [Table S5](#mmc1){ref-type="supplementary-material"}.

RT-PCR, PCR, and Real-Time PCR {#sec4.8}
------------------------------

Total RNA from cultured cells was extracted by TRIzol and reverse-transcribed using a cDNA Synthesis Kit (TaKaRa Biotechnology). PCR and real-time PCR were performed as described previously ([@bib42]) on a Bio-Rad thermal cycler (Bio-Rad) and a Stratagene Mx3000P (Stratagene, CA, USA), respectively. Primers are listed in [Table S5](#mmc1){ref-type="supplementary-material"}.

Teratoma Formation Assay {#sec4.9}
------------------------

A confluent 10-cm dish containing 1--5 × 10^6^ PSCs were digested into small clumps by collagenase IV (Gibco), resuspended with Matrigel (Gibco), and then injected subcutaneously in severe combined immunodeficient (SCID) mice, as previously described ([@bib42]). Visible tumors were formed between 5 and 8 weeks post injection and teratoma sections were examined by hematoxylin-eosin staining. All animal experimental procedures were conducted in accordance with the local Animal Welfare Act and Public Health Service Policy with approval from the Committee of Animal Experimental Ethics at East China Normal University (protocol no. m20170320).

Statistical Analysis {#sec4.10}
--------------------

Data are presented as mean ± SE (SEM). All experiments were performed independently for more than three times unless otherwise stated. Statistical analyses were conducted with unpaired Student\'s t test using Prism Graphic software.

Other experimental methods including RNA sequencing and analyses were described in details in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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